CompuMed Inc. (OTCMKTS:CMPD – Get Free Report)’s share price traded down 0.3% on Wednesday . The company traded as low as $6.00 and last traded at $6.70. Approximately 1,092 shares were traded during mid-day trading, an increase of 33% from the average session volume of 818 shares. The stock had previously closed at $6.72.
CompuMed Price Performance
The firm has a market cap of $8.91 million, a P/E ratio of -44.66 and a beta of -0.47. The business’s fifty day simple moving average is $6.38 and its 200-day simple moving average is $5.81. The company has a current ratio of 2.37, a quick ratio of 2.34 and a debt-to-equity ratio of 0.12.
CompuMed (OTCMKTS:CMPD – Get Free Report) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.06) EPS for the quarter. The company had revenue of $2.03 million during the quarter. CompuMed had a negative return on equity of 6.47% and a negative net margin of 2.51%.
About CompuMed
CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.
Featured Articles
- Five stocks we like better than CompuMed
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.
